Department of Obstetrics and Gynaecology

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer (2026) Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, et al. Journal article Analyzing and adapting diffusion segmentation behavior for medical images (2026) Öttl M, Mei S, Wilm F, Qiu J, Steenpaß J, Rübner M, Hartmann A, et al. Journal article Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer (2026) Jhaveri KL, Iyengar NM, Turner NC, Rugo HS, O'Shaughnessy J, Barrios CH, Curigliano G, et al. Journal article, Review article Standardized patient coaching improves therapy persistence in patients with hormone receptor–positive, HER2–negative advanced/metastatic breast cancer treated with abemaciclib (2026) Welslau M, Fasching P, Semmler-Lins N, Mueller L, Belleville E, Rieger L, Uhrig S, et al. Journal article Using smart devices for prenatal care: Assessing the willingness among women with pregnancy-related anxiety (2026) Altmannshofer S, Weidenthaler F, Titzmann A, Pontones C, Danzberger N, Jäger K, Nissen M, et al. Journal article, Original article Using AI in breast cancer KI beim Mammakarzinom (2026) Hübner H, Seitz K, Leutheuser H Journal article Setting of Induction of Labour with Double-Balloon Catheter in Low-risk Pregnancies: Outpatient Versus Inpatient (2026) Kehl S, Gernhardt A, Weiss C, Schneider M, Beckmann M, Pretscher J Journal article ABC8 Consensus: Assessment by a German Group of Experts (2026) Ditsch N, Untch M, Fasching P, Briest S, Ettl J, Haidinger R, Lüftner D, et al. Journal article Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025) Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al. Journal article Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX) (2025) Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, et al. Journal article